Indian J Pharm Close
 

Figure 2: Risk of a) CHD mortality, b) CVD mortality and c) all-cause mortality, in the treatment group, compared to that in placebo. For References, compare the patient numbers in both arms in Table 1. The treatment and control columns present the number of deaths by the total number of randomized patients in that arm. The weight represents the relative weight given to the study. The fi nal column gives the point estimate of relative risk and its 95% confi dence interval.

Figure 2: Risk of a) CHD mortality, b) CVD mortality and c) all-cause mortality, in the treatment group, compared to that in placebo. For References, compare the patient numbers in both arms in Table 1. The treatment and control columns present the number of deaths by the total number of randomized patients in that arm. The weight represents the relative weight given to the study. The fi nal column gives the point estimate of relative risk and its 95% confi dence interval.